ASCO 2020: Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumours
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed…
Browsing: head and neck cancer
Study suggests aspirin may help some patients survive head and neck cancer
Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with…
Early trauma may be risk factor for anxiety and depression in adults with head/neck cancer
Among individuals with head and neck cancer (HNC), those who experienced childhood trauma were more…
Voice problems: Updates to treatment and care of patients with hoarseness
The American Academy of Otolaryngology—Head and Neck Surgery Foundation published the Clinical Practice Guideline: Hoarseness…
Experimental drug trial seeks to improve treatment for head and neck cancer
A trial to test an experimental drug in patients with head and neck cancer launches…
ECCO 2017: Twice-daily radiation therapy cuts deaths from head and neck cancer
Treating head and neck cancer patients with a twice-daily radiation therapy combined with chemotherapy could…
A surprise advance in the treatment of adult cancers
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC)…
IARC study identifies new genetic factors linked to HPV-related cancers
A new large-scale genetic study of head and neck cancers shows why some individuals infected…
‘Game-changing’ immunotherapy doubles head and neck cancer survival
An immunotherapy drug has been hailed as a potential ‘game changer’ after being found to…
Coffee won’t give you cancer, unless it’s very very hot, then it might
By Bernard Stewart, UNSW Australia. The World Health Organisation’s cancer arm made two announcements this week:…